04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
The sudden arrival of the COVID-19 pandemic in the first quarter of 2020 shocked an M&A market that ...
Read More >
Over the last five years, many private equity market participants have become acquainted with a “GP...
Read More >
In this episode of Great Women in Compliance, Lisa speaks with Andrea Bonime Blanc, who has "done it...
Read More >
Seyfarth Synopsis: The U.S. Bureau of Labor Statistics (BLS) recently released its annual National C...
Read More >
On September 21, 2020, the Federal Trade Commission (the “FTC”) announced proposed amendments that...
Read More >
According to the most recent statistics from the Canadian Cannabis Survey (CCS), 5% of people survey...
Read More >